PRMT5-FOXM1 axis activates β-catenin/IL8 signaling to drive angiogenesis of gastric cancer
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.111925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Xinyu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, 450052 Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Stomach Neoplasms, Interleukin-8, beta Catenin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Henan Provincial Science and Technology Research Project.
Abstract (Originalsprache)
Protein arginine methyltransferase 5 (PRMT5) functions as an oncogene to regulate cell proliferation and metastasis in many cancers. However, little is known about the role of PRMT5 in tumor angiogenesis. Here, we reported PRMT5 exhibited pro-angiogenic roles in gastric cancer (GC). We observed PRMT5 expression was markedly correlated with microvessel density in GC. Cytological experiment indicated that PRMT5 overexpression promoted tube formation, proliferation, and migration of Human Umbilical Vein Endothelial Cells. However, PRMT5 depletion or enzymatic inhibition restrained these processes. Our in vivo experiments demonstrated that enzymatic inhibition of PRMT5 suppressed angiogenesis of chicken embryo chorioallantoic membranes and mouse xenograft tumors. Mechanistically, we observed PRMT5 up-regulated IL8 expression through activating β-catenin signaling. Evaluation of PRMT5-induced epigenetic marks revealed that PRMT5 depletion erased H3R8me2s from the promotor of Forkhead Box M1 (FOXM1), and finally decreased IL8 transcription. Our results demonstrated the pro-angiogenic effect of PRMT5-FOXM1-IL8 axis in GC, providing a novel approach of targeting such epigenetic regulators in this deadly disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, 450052 Zhengzhou, Henan, China.
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, 450052 Zhengzhou, Henan, China. Electronic address: yeyanwei66@163.com.
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, 450052 Zhengzhou, Henan, China. Electronic address: masterlxy@alumni.sjtu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Liu, X., Tu, C., Yang, H., Tang, B., Ye, Y., & Wang, H. (2025). PRMT5-FOXM1 axis activates β-catenin/IL8 signaling to drive angiogenesis of gastric cancer. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.111925
Vancouver
Liu X, Tu C, Yang H, Tang B, Ye Y, Wang H. PRMT5-FOXM1 axis activates β-catenin/IL8 signaling to drive angiogenesis of gastric cancer. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.111925
BibTeX
@article{Liu2025,
author = {Liu, Xinyu and Tu, Chenxiao and Yang, Hongwei and Tang, Bowen and Ye, Yanwei and Wang, Huanan},
title = {PRMT5-FOXM1 axis activates β-catenin/IL8 signaling to drive angiogenesis of gastric cancer},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.111925}
}
EUVIMED